Chemestmed Wraps Up a Successful Three Days at BIO-Europe
The Chemestmed team has returned from three productive and inspiring days at BIO-Europe in Vienna, where our representatives, Sigrid Selberg and Mati Karelson engaged with a wide network of industry experts, innovators, and partners from across the biotech landscape.
Throughout the conference, we had the opportunity to present our advancing METTL3 activator and METTL16 inhibitor programs. The level of interest, insightful discussions, and constructive feedback we received were truly encouraging and will play an important role in guiding the next steps of our development work.
The event also offered memorable experiences outside the meeting rooms, including the remarkable reception at the Hofburg Palace, a beautiful setting that added a special touch to the conference.
Now back in Tartu, our team is focused on following up on the many meaningful conversations and exploring the new collaboration opportunities that emerged during the event.
A warm thank you to everyone we met!
Thank you, Vienna!
